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Abstract
Objectives The aim of these investigations was to assess the
ability of two fluoride dentifrices to protect against the initia-
tion and progression of dental erosion using a predictive
in vitro erosion cycling model and a human in situ erosion
prevention clinical trial for verification of effectiveness.
Materials and methods A stabilized stannous fluoride (SnF2)
dentifrice (0.454 % SnF2 + 0.077 % sodium fluoride [NaF];
total F = 1450 ppm F) [dentifrice A] and a sodium
monofluorophosphate [SMFP]/arginine dentifrice (1.1 %
SMFP + 1.5 % arginine; total F = 1450 ppm F) [dentifrice
B] were tested in a 5-day in vitro erosion cycling model and a
10-day randomized, controlled, double-blind, two-treatment,
four-period crossover in situ clinical trial. In each study, hu-
man enamel specimens were exposed to repetitive product
treatments using a standardized dilution of test products
followed by erosive acid challenges in a systematic fashion.
Results Both studies demonstrated statistically significant dif-
ferences between the two products, with dentifrice A provid-
ing significantly better enamel protection in each study.
In vitro, dentifrice A provided a 75.8 % benefit over dentifrice
B (p < 0.05, ANOVA), while after 10 days in the in situmodel,
dentifrice A provided 93.9 % greater protection versus denti-
frice B (p < 0.0001, general linear mixed model).
Conclusion These results support the superiority of stabilized
SnF2 dentifrices for protecting human teeth against the initia-
tion and progression of dental erosion.
Clinical relevance Stabilized SnF2 dentifrices may provide
more significant benefits to consumers than conventional
fluoride dentifrices.
Keywords Erosion . Tooth wear . Dentifrice . Clinical trial
Introduction
Dental erosion is a condition of growing concern that is prev-
alent globally in both children and adults. Some researchers
have reported that it is present in more than half of all adoles-
cents [1–3]. The manifestation of dental erosion is primarily
due to the excessive exposure of the teeth to acid-containing
beverages and foods as well as gastric acid associated with
gastroesophageal reflux disease (GERD) and bulimia [4, 5].
Dental erosion involves the demineralization and softening of
the tooth surface which, once softened, is highly susceptible to
further erosion due to forces related to abrasion and attrition,
such as tongue friction and shear [6–8]. Importantly, as op-
posed to caries, which is a reversible condition when treated in
its early stages, dental erosion is considered to be essentially
irreversible, since mineral is being lost directly from the sur-
face, rather than subsurface areas, of the affected teeth [8, 9].
There is a growing concern by dental professionals that dental
erosion may represent a significant threat to the long-term
health and integrity of tooth structure, necessitating interven-
tion approaches designed tominimize any permanent damage.
As a result, preventive strategies designed to protect exposed
tooth surfaces against the initiation and progression of dental
erosion are of high interest to the dental community [9, 10].
There are two distinct approaches to prevention of dental
erosion that have been the focus of targeted research. One is to
minimize the likelihood for dietary products to cause dental
erosion at the source by reducing the erosive potential of acid-
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containing beverages and foods [8–11]; the other is to utilize
oral care products to deliver a protective barrier onto exposed
tooth surfaces that can serve as either a sacrificial layer or as a
coating to repel erosive acid challenges [12–14]. The first of
these approaches has resulted in minimal success. One issue
with this approach is the likelihood of adversely modifying the
taste of the acidic products when incorporating ingredients
designed to minimize their erosive potential [8]. The develop-
ment of oral care products that are specifically designed to
help protect enamel against an increased level of erosive acid
challenge, however, has been far more successful [12–15].
Oral care products are routinely used at least once a day by
most individuals, and many people use them twice a day. This
type of usage pattern makes oral care regimens perfectly suit-
ed to delivering product therapies that can deposit on and be
retained on exposed tooth surfaces for extended periods of
time and help protect these tooth surfaces against erosive acid
challenges at time points beyond the initial use of the products
[13, 16–18].
While many modern fluoride-containing products have
been shown to provide some level of erosion benefit [12,
19], products formulated with stabilized SnF2 have been con-
firmed to be particularly effective, depositing a long-lasting
barrier layer onto pellicle-coated tooth surfaces that is capable
of withstanding erosive acid challenges for extended periods
of time post treatment [13, 16–18, 20, 21].
A new fluoride dentifrice has recently been launched con-
taining a combination of 1450 ppm F as sodium
monofluorophosphate (SMFP), 1.5 % arginine, and calcium
carbonate. The manufacturer of this dentifrice markets this
product as providing enhanced enamel strengthening and su-
perior cavity protection, due, in part, to the product’s claimed
ability to neutralize plaque acids from consumption of dietary
sugar [22]. Dentifrices formulated with combinations of
SMFP, arginine, and calcium have been shown to be effective
against caries [23], hypersensitivity [24], and dental erosion
[25], although none of these studies compared the effective-
ness of the arginine-based formulation versus a stabilized
SnF2 dentifrice.
In order to determine the most appropriate oral care prod-
ucts for patient needs, there is an ongoing interest in the rela-
tive effectiveness of different products to help prevent dental
erosion. In situ clinical and in vitro model studies have proven
beneficial in measuring the relative erosion-protective effec-
tiveness of different products. Both of the models presented
here have been successfully used in the past either to predict
the potential effectiveness of oral care products [16–18] or to
confirm their effectiveness under human use conditions [20,
21]. The aims of this study were to compare the two marketed
dentifrices for their ability to provide erosion protection ben-
efits, using different chemistries, and to test whether these
independent approaches result in differences in the erosion
protection potential of the two dentifrices.
Methods and materials
Test products
The following dentifrices, formulated with a total of
1450 ppm F, were tested in both the in vitro and in situ studies:
& 0.454 % SnF2 + 0.077 % NaF (1450 ppm fluoride),
marketed as Oral-B® Pro-Expert dentifrice (The Procter
& Gamble Company, Gross Gerau, Germany)
& 1.1 % SMFP (1450 ppm fluoride) with 1.5 % arginine,
marketed as Colgate® Maximum Cavity Protection plus
Sugar Acid Neutralizer Dentifrice (Colgate-Palmolive
Co., Kolombiya, Turkey)
In addition, the in vitro study included a product containing
0.454 % (1100 ppm) F as stabilized SnF2 (Crest® Pro-Health
dentifrice, The Procter and Gamble Company, Cincinnati,
OH, USA) that has been previously demonstrated in both
in vitro and human in situ clinical trials to provide significant
erosion protection benefits [16–18, 20, 26, 27].
In vitro study design
For the in vitro study, preparation of specimens and treatment
regimen followed exactly the established protocol of Faller
[17, 18]. Briefly, ground and polished cores of sound, pelli-
cle-coated, human enamel, mounted in lucite rods, were treat-
ed in a 1:3 slurry (5 g of dentifrice/15 g of fresh, pooled human
saliva) four times per day (2 min each) for a total of five
treatment days. Erosive acid challenges were made by soaking
each treatment group of four enamel specimens in 1 % citric
acid at neat pH (approximately 2.3) for 10 min at room tem-
perature, 1 h after each dentifrice slurry treatment. Both the
product slurry treatments and the erosive acid challenges were
carried out with each group of test specimens fitted to a spe-
cially designed holder and suspended into the appropriate
mixture while being rotated at a controlled speed of 75 rpm
to provide a constant shear. At all times specimens were not in
treatment or erosive challenge, they remained in pooled, hu-
man saliva that was freshened three times each day.
Assessment of surface enamel loss was made via direct mea-
surement of cross-sectional samples taken from each speci-
men after completion of all treatments (Fig. 1).
Collection of human salivaApproximately eight healthy vol-
unteers were recruited to provide human saliva for this study.
Fresh saliva was collected from volunteers each day of the
study. Each volunteer chewed paraffin wax and expectorated
the stimulated saliva into a plastic cup over a period of ap-
proximately 30 min per collection period. The saliva collected
from the group of volunteers was then pooled and stored in the
refrigerator at 5 °C until use.
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Specimen collection and preparation Enamel samples used
in this study were prepared from human teeth. The teeth were
obtained from local oral surgeons who collected them after
removal, typically for orthodontic reasons. Teeth were indi-
vidually cleaned and checked for any visible cracks or surface
imperfections. Those with visible imperfections were
discarded. Teeth were stored in the refrigerator in a 1 % thy-
mol solution at 5 °C until use.
Required precautions were in place to ensure proper han-
dling of teeth and saliva from the point of collection to their
use in the laboratory study.
In situ clinical trial
Ethical approval for the human in situ clinical study was
granted by the UK National Research Ethics Service, and
the study was designed and managed in compliance with the
principles of good clinical practice. All participants received
verbal and written information concerning the study and gave
signed and witnessed consent to participate. An individual,
not otherwise involved in the study, monitored the conduct
of the study and the case record forms. The trial was a sin-
gle-center, double-blind, randomized, supervised-usage, two-
treatment, four-period crossover study. Additional periods, in
this case a four-period crossover design, allow greater statis-
tical power for detecting treatment differences in lieu of addi-
tional subjects and help to minimize the influence of individ-
ual periods. A sufficient number of participants were recruited
to enroll approximately 36 participants and complete the study
with at least 30 evaluable participants. Each study participant
was specially fitted with an upper palatal intraoral appliance
containing two enamel samples that was worn on each treat-
ment day of the study, which was retained within their mouth
using wire clasps on suitable posterior teeth.
Participants were randomly assigned at study initiation to a
treatment sequence ordering their use of the two commercially
available test dentifrices. Participants presented for four study
periods, were randomized to treatment sequences, and received
one of two dentifrices each period on test days at the clinical
site. Each study period took place over a span of 2 weeks and
was composed of 10 treatment days, which were conducted on
weekdays only (Monday to Friday). This study was a variation
of the previously published method of Hooper et al. [20].
Prior and concomitant therapy
At the beginning of the study, participants were instructed to
refrain from using any prescription or non-prescription oral
care products, which were not assigned test articles through-
out the duration of the study. Participants were also instructed
to refrain from receiving oral prophylaxis or any other elective
dental procedures throughout the duration of the study.
In situ product use
Assigned test dentifrices were administered in the form of a
slurry on each treatment day to each participant prior to the
erosive challenge. Clinical site personnel prepared the denti-
frice slurries for each participant by mixing 3 g of dentifrice
with 10 mL of water. Participants were unaware of the product
identity of their assigned dentifrice slurry, and they were
instructed not to discuss the physical properties of their
assigned products with other study participants or clinical site
personnel. In addition, to maintain blinding, the investigator
and personnel performing and recording the surface
profilometry assessments had no access to the product dis-
pensing room during treatments. At screening, the participants
were provided with a non-treatment 0.32 % NaF (1450 ppm
fluoride) marketed dentifrice (Crest® Decay Protection denti-
frice: The Procter & Gamble Company, UK) and manual
toothbrushes (Oral-B® 35 manual toothbrush: The Procter &
Gamble Company, Cincinnati, OH, USA) for use at home
until the follow-up visit. The participants were required to
use these products in place of their normal oral care products,
twice per day (morning and evening), for the duration of the
study, including treatment days, weekends, and leave days.
In situ study design
On each treatment day, participants brushed their teeth at
home in their usual manner using the non-treatment dentifrice
and manual toothbrush. Participants then visited the clinical
Fig. 1 Cross-sectional
micrograph of in vitro-treated
specimen showing area of tooth
surface loss
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trial unit where they collected their upper palatal intraoral
appliance fitted with two enamel samples and placed it in their
mouth. While wearing the appliance (approximately 6 h in
total each day), participants swished twice a day for 60 s with
their assigned dentifrice slurry under the supervision of clinic
staff. The erosive challenge occurred with the appliance in
their mouth. The participants sipped 25 mL of orange juice
(Sainsbury’s Supermarkets Ltd., 33 Holborn, London,
EC1N2HT) over a timed minute, swished it around their
mouth and over the enamel specimens in order to generate
shear forces, and then spit it out. The procedure was repeated
10 times per challenge so that the enamel samples were ex-
posed to a total of 250 mL of orange juice over a 10-min
period. The erosive acid challenge was carried out a total of
four times on each treatment day.
Enamel samples were measured for tissue loss using a cal-
ibrated contact surface profilometer (Mitutoyo (UK) Ltd.,
Joule Road, Andover, Hampshire UK). Measurements were
taken at baseline prior to the start of the study and at the end of
treatment day 10. Fresh enamel samples were placed in the
intra-oral appliance at the beginning of each treatment period.
Preparation of enamel samples for the in situ study
Prior to the beginning of the study, enamel samples were pre-
pared and a baseline profilometry measurement was obtained
for each sample. Enamel specimens were obtained from
caries-free human third molars that had been recently extract-
ed and donated by patients aged 18 years and older, of either
gender, to a licensed tissue bank (Bristol Dental School and
Hospital Tooth Tissue Bank, REC Ref: 11/N1/0145). Upon
donation to the tissue bank, teeth were soaked in a 20,000-
ppm available chlorine solution (Haz-Tab Tablets, Guest
Medical, Aylesford, Kent UK) for at least 24 h. The teeth were
cleaned; the root was sectioned from the crown to enable
dental pulp removal and disposal and then soaked for a sub-
sequent 24 h in a solution containing 20,000 ppm available
chlorine. The teeth were then soaked in distilled water and
stored in the tissue bank in a solution containing 5000 ppm
available chlorine until use.
Tooth crowns obtained from the tissue bank were sectioned
into 1-mm slices using a microslice (Ultra Tec Ltd., Santa
Ana, CA, USA) to produce enamel samples, which were fur-
ther trimmed as needed using a high-speed handpiece and
diamond bur. Each enamel sample was then placed with the
test surface facing down in a mold 6 mm × 8 mm × 2 mm
(width, length, and depth, respectively) and filled with epoxy
resin. After 24 h, once the epoxy resin had cured, samples
were removed. Each specimen was then hand polished using
a standardized series of silicon carbide papers, silica powders,
and polishing techniques until the surface of each specimen
was sufficiently smooth and shiny, as determined through vi-
sual inspection by a trained laboratory technician.
Two baseline readings of each enamel sample were then
taken using contact profilometry. Each sample was identified
with a unique number on the reverse of the sample using a
permanent marker and then masked with a PVC tape on either
side of a 2–3-mm-wide window of enamel.
Fresh enamel samples were placed in the intra-oral appli-
ance at the beginning of each of the four study periods. The
enamel samples were retained within the appliance using wire
clasps, one in the anterior of the mid-hard palate and one in the
posterior region of the mid-hard palate. The appliances (con-
taining the enamel samples) were dipped in Corsodyl® mouth
rinse (0.2 % w/v chlorhexidine gluconate; GlaxoSmithKline
Consumer Healthcare, Brentford, Middlesex, UK) twice daily
for approximately 3 min and briefly rinsed in tap water at the
start of the treatment day and upon removal from the mouth at
the end of each treatment day. The appliances were removed
for up to a 1-h period over lunch and also overnight until the
next day. When removed at these times, the appliances were
stored in a pot containing a damp cotton wool pad, moistened
with water. Samples were removed from the appliances at the
end of day 10 for duplicate profilometry measurements. Prior
to making profilometry measurements, each appliance was
disinfected by soaking in a mixture of 0.5 % chlorhexidine
and 70 % aqueous ethanol for a period of at least 20 min, and
then, the samples and tape were removed.
Statistical methods
The in vitro study was analyzed for mean differences between
groups using one-way analysis of variance, including the
Games-Howell post hoc multiple comparison procedure since
the groups demonstrated unequal variances. The primary mea-
sure of efficacy in the in situ trial was the amount of dental
erosion that had occurred, measured by profilometry, at day
10. For each participant and treatment period, the average of
four erosion profilometry measurements was calculated using
two replicate measurements from each of two enamel sec-
tions. Since the day 10 enamel loss distribution was right-
skewed, the data were transformed using the natural log func-
tion to make the distribution bell-shaped before performing
between-treatment analysis that assumed normality. A general
linear mixed model was used to compare treatments, and the
final model included baseline, period, and treatment as fixed
effects and participant as a random effect. The carryover effect
was not statistically significant (p = 0.71) and was removed
from the statistical model. From the final statistical model,
estimated means on the natural log scale were back-
transformed by using the exponential function (emean) to ob-
tain the estimated medians of 50th percentiles on the original
scale (μm), and 95 % confidence intervals (CI) were calculat-
ed. All statistical comparisons were two-sided with a signifi-
cance level of 0.05. The null hypothesis tested in the human
clinical study at day 10 was that the mean dental erosion was
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equal between the treatment differences, with the alternative
hypothesis being that the mean dental erosion was not equal
between the treatment differences.
Results
In the in vitro study, specimens treated with the stabilized
SnF2 dentifrice resulted in an average enamel surface loss
(SEM) of 5.75 μm (1.03), compared to an average loss of
23.75 μm (4.27) for the SMFP/arginine dentifrice, which in-
dicates a 75.8 % benefit in protecting the enamel against ero-
sive acid damage, in favor of the stabilized SnF2 dentifrice.
Compared to the positive control, the SMFP/arginine denti-
frice performed at a level that was significantly less effective
than this clinically proven reference product, while the stabi-
lized SnF2 dentifrice provided an equivalent level of effective-
ness (Table 1).
In the in situ evaluation, 34 participants (mean age
44.6 years) were randomized to treatment; 33 participants
completed the final study visit. The baseline profilometry
measurements of the surface of specimens included in the in
situ study were nearly zero, with means (SE) of −0.090
(0.0095) and −0.069 (0.0095) for the stabilized SnF2 and
SMFP/arginine dentifrices, respectively. Due to a low stan-
dard error of the mean, a statistically significant difference
(p < 0.05) was observed between the two test dentifrices at
baseline. To address this in the statistical model for the day 10
treatment comparisons, baseline was used as a covariate to
obtain adjusted means for each test dentifrice. Despite the
statistically significant baseline mean difference of 0.021,
the day 10 treatment mean difference was nearly 55 times
larger.
At day 10, the stabilized SnF2 dentifrice demonstrated a
statistically significant (p < 0.0001) 93.9 % better protection
against erosion versus the SMFP/arginine dentifrice with esti-
mated enamel loss medians (CI) of 0.075 μm (0.060, 0.093)
for the stabilized SnF2 dentifrice and 1.226 μm (0.980, 1.532)
for the SMFP/arginine dentifrice (Table 2). On the natural log
scale, the estimated means from the statistical model were
calculated for the dentifrices, and the estimated medians in
micrometers, above, were calculated by applying the expo-
nential function (Table 2). The SnF2 dentifrice resulted in
more than 10 times better enamel protection versus the
SMFP/arginine dentifrice. A distribution box plot of enamel
loss by treatment (Fig. 2) verifies distinct differences in per-
formance between the two test dentifrices at day 10. Both
dentifrices were well tolerated. There were no adverse events
in the study.
Discussion
The use of in vitro models designed to simulate conditions of
excessive erosive acid ingestion has proven to be valuable for
predicting the likely erosion protecting performance of oral
care products when tested under conditions of actual human
use. One of the primary benefits to the use of in vitro models is
the ability to control conditions in such a way that all treat-
ments are done in an essentially identical manner.
Standardization in the in vitro models also generally results
in lower variability that is helpful for predicting ultimate per-
formance in human clinical studies.
Stabilized stannous fluoride dentifrices have been compre-
hensively evaluated against a broad range of marketed prod-
ucts in well-credentialed, standardized, and validated in vitro
and in situ model studies, with the results of these studies
published in several peer-reviewed journals [16–18, 20, 21,
27, 29]. The credentialed in vitro model has proven to be a
strong predictor of in situ performance and, for that reason,
has been included in this report where the same two products
included in the in situ study were tested, along with a positive
control, 1100 ppm F as SnF2, dentifrice.
In the present paper, the results predicted by the in vitro
erosion cycling model were subsequently confirmed in the
human in situ clinical trial, with both studies demonstrating
Table 1 In vitro efficacy results
In vitro efficacy results—treatment comparison of surface loss (μm) (N = 4/treatment group)
Treatment group Key formulation
components
Surface loss (μm)
± (SEM)a
Statistical
grouping
% Reduction vs.
SMFP/arginine
Stabilized SnF2 control 1100 ppm F as SnF2 4.25 (0.95) A 82.1
Silica abrasive
Stabilized SnF2 1100 ppm F as SnF2 5.75 (1.03) A 75.8
350 ppm F as NaF
Silica abrasive
SMFP/1.5 % arginine 1450 ppm F as SMFP 23.75 (4.27) B –
1.5 % arginine
CaCO3 abrasive
aMeans with different letter designations are significantly different (p < 0.05)
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that the stabilized SnF2 dentifrice provided high percentage
differences in performance compared to the SMFP/arginine
dentifrice. The erosion cycling model provides a useful simu-
lation of the process of dental erosion, beginning with sound,
pellicle-coated human enamel, subjecting the pellicle-coated
enamel to erosive acid challenges for controlled periods of
time that mimic human use of erosive acid beverages, bathing
in pooled, human saliva to allow remineralization processes to
occur, and incorporation of shear forces capable of removing
softened enamel from the treated surfaces. In the in situmodel,
specimens are exposed to natural saliva flow, enabling the
deposition of a naturally formed pellicle on the enamel spec-
imens. Both models reported here are well accepted to assess
the ability of each test product to protect sound, treated sur-
faces against tooth surface loss due to erosive acid challenge,
which was the objective of this research. Neither model
includes direct, physical brushing (i.e., abrasion) of the enam-
el specimens as that was not the objective of these studies.
Other research groups have made attempts to incorporate
abrasion into either in vitro [30–34] or in situ [35, 36] models.
At times, these models show similar rank-ordered results
when comparing the erosion only versus erosion–abrasion
results [32, 34, 35]. In other studies, results were different
when comparing erosion to erosion–abrasion outcomes [30,
31, 33]. Thus, to ensure the single-variable objective of this
research, brushingwas not included. Results should be viewed
in this context when extrapolating them to the oral environ-
ment. Further evolution of these models, to assess both the
chemical erosion-preventive effects of the paste in addition to
the effects of a mechanical intervention, should be a topic for
future research.
One issue faced by researchers conducting human erosion
studies is the safety of the subjects’ natural teeth against the
erosive conditions prescribed by the study protocol. The study
design used in the current evaluation is considered to be
completely safe for the subjects’ natural teeth, as it is not
expected to cause any significant loss of enamel. Subjects
are evaluated prior to the study to ensure that they show min-
imal evidence of tooth wear. The protocol required that if any
subject lost 20 μm or more of the test enamel, the subject
would be pulled immediately from the study. As the results
demonstrate (Table 2), the total amount of loss on the speci-
mens treated with the less effective product resulted in only a
few microns of surface lost over the duration of the study.
Results of the current study are in line with previously
published results that made use of the same in vitro model
as well as the same, or similar, in situ models. Evaluations
of a marketed, stabilized SnF2 dentifrice using the in vitro
erosion cycling model demonstrated results favoring the sta-
bilized SnF2 dentifrice by 65–86 % over other marketed prod-
ucts tested [16–18]. Published in situ evaluations have result-
ed in 56–87 % benefits in erosion prevention relative to com-
parator products [20, 21, 27], depending on the study design.
The ability of different formulations to deposit onto treated
surfaces and strengthen those surfaces against erosive acids,
thereby minimizing the potential for irreversible tooth surface
Table 2 Day 10 in situ efficacy results
In situ efficacy results—treatment comparison of profilometry levels (μm) general linear mixed model evaluable participants (N = 34)
Visit/treatment Original scale in μm
estimated median (SE)a
95 % Confidence interval
of the estimated mean
Natural log scale
mean (SE)
% Reduction vs. SMFP/
arginine (p value)b
10 days post baseline (participant variance = 0.0264, residual variance = 0.7869)
Stabilized SnF2 0.0747 (0.008) (0.060, 0.093) −2.5946 (0.1116) 93.9 % (p < 0.0001)
SMFP/1.5 % arginine 1.2255 (0.138) (0.980, 1.532) 0.2033 (0.1125)
a Estimated medians in micrometer were obtained by using the exponential function on the means from the natural logarithm scale (emean )
b Percent reduction was calculated using back-transformedmeans as 100% (SMFP/1.5% arginine − Stabilized SnF2) / SMFP/1.5 % arginine. Two-sided
p values for testing the mean difference between treatments were provided
Fig. 2 Distribution box plot—enamel loss data (μm) at day 10
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loss, is an important factor to consider when assessing the
potential effectiveness of oral care products. Products formu-
lated with either stabilized SnF2 or arginine, calcium, and
SMFP are claimed to be effective against caries as well as
hypersensitivity, with erosion being an etiological factor for
dentin hypersensitivity as an outcome of the loss of the enamel
and or cementum and the loss of the outermost layers of min-
eral that coat the dentin tubules [28, 29]. Although both types
of formulations included in the current study make claims of
sensitivity benefits as well as erosion protection, they do so
via different chemistries.
With respect to the ability of arginine, calcium, and SMFP
to reduce sensitivity, the manufacturer claims the Btechnology
works by physically sealing dentin tubules with a plug that
contains arginine, calcium carbonate, and phosphate^ and it is
this mass that reduces acid solubility [37]. Thus, the chemistry
is essentially a calcium phosphate deposit. It is likely that this
same type of surface deposit would also be responsible for any
erosion protection benefit delivered to enamel, since both hy-
persensitivity and dental erosion are eventual outcomes that
may result from similar types of acid challenges. Stabilized
SnF2 dentifrices have been demonstrated to physically seal
exposed dentin tubules via the chemical precipitation of a
stannous-rich, acid-resistant smear layer [38, 39]. Deposition
of an acid-resistant smear layer is likely the key mechanism
for protection of dentin against both sensitivity and dental
erosion. Smear layers act in a sacrificial manner, preferentially
dissolving prior to the acid attacking the dentin itself, resulting
in neutralization of the acid challenge. Studies by Rees et al.
[40] and Pinto et al. [41] assessed the impact of acid-
containing beverages on smear layer removal, finding that
more aggressive beverages (measured in terms of pH, acid
type, acid content, and titratable acidity) resulted in faster
removal of the smear layer and more rapid exposure of oc-
cluded tubules. The overall aggressiveness of an acid chal-
lenge against dentin can be reduced by deposition of a more
acid-resistant smear layer. Studies by White et al. [42] report-
ed that dentin treated in vitro with a stabilized SnF2 dentifrice
resulted in enhanced resistance to acid dissolution and tubule
exposure. In addition to its ability to deposit on dentin sur-
faces, SnF2 has been shown to deposit onto hydroxyapatite
surfaces [43], and stabilized SnF2 dentifrices have been shown
to deposit a protective, acid-resistant, stannous-containing
barrier layer onto both sound enamel and pellicle-coated
enamel surfaces [13, 14]. Importantly, the stannous-
containing barrier layer has been demonstrated to remain on
the pellicle-coated tooth surfaces for at least several hours
after treatment [13].
The barrier layer formed after treatment with stannous-
containing products is most likely composed of either stan-
nous fluorophosphate or stannous oxide compounds [19], ei-
ther of which would be expected to provide significantly
higher resistance to erosive acids compared to a precipitate
composed primarily of calcium and phosphate, which is likely
the type of deposit delivered from dentifrices containing
SMFP, arginine, and calcium [16, 26, 30]. Importantly, the
in situ human clinical trial demonstrated greater than 10 times
better enamel protection associated with the deposition of an
acid-resistant, stannous-containing barrier layer.
Results from the current studies support the superiority of
stabilized SnF2 dentifrices for protecting human teeth against
the initiation and progression of dental erosion.
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